CD44 and leukemia: From a more in-depth analysis of the distribution/expression pattern of the single proteoglycans, CD44 appears to be most ubiquitous proteoglycan across hematologic neoplasia, being also abundant on leukemia-initiating stem cells ( [32]; Fig. 4).